Add Company
Join Now

Ambagon Therapeutics Revenue and Competitors

License our Company Data API

Location

$103M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Ambagon Therapeutics's estimated annual revenue is currently $12.2M per year.(i)
  • Ambagon Therapeutics's estimated revenue per employee is $155,000
  • Ambagon Therapeutics's total funding is $103M.

Employee Data

  • Ambagon Therapeutics has 79 Employees.(i)
  • Ambagon Therapeutics grew their employee count by 10% last year.

Ambagon Therapeutics's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Founder, CTOReveal Email/Phone
3
Co-FounderReveal Email/Phone
4
Co-FounderReveal Email/Phone
5
Head Research and InnovationReveal Email/Phone
6
VP & Head, Corporate Strategy & Business DevelopmentReveal Email/Phone
7
Associate DirectorReveal Email/Phone
8
Associate Project ManagerReveal Email/Phone
9
Senior Scientist II, Lung BiologyReveal Email/Phone
10
ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.4M70-8%$53MN/A
#2
$32.4M167-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.8M1813%N/AN/A
#5
$0.8M5-50%N/AN/A
#6
$0.8M100%N/AN/A
#7
$14M90-12%N/AN/A
#8
$0.4M33610%$236.7MN/A
#9
$4.8M62-74%$160MN/A
#10
$3.7M24-8%N/AN/A
Add Company

What Is Ambagon Therapeutics?

Ambagon is discovering and developing small molecule cancer drugs that stabilize the direct interaction of oncogenic proteins with the 14-3-3 class of adaptor proteins. Ambagon’s platform approach will open opportunities to address major unmet clinical needs beyond oncology.

keywords:N/A

$103M

Total Funding

79

Number of Employees

$12.2M

Revenue (est)

10%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$11.5M7920%$31.9M
#2
$9.5M795%N/A
#3
$16M79N/AN/A
#4
$11.5M79N/AN/A
#5
$25.7M79N/AN/A